Patient organ and effective dose estimation in radionuclide therapy with <sup>223</sup>Ra -dichloride

Patient organ and effective dose estimation in radionuclide therapy with <sup>223</sup>Ra -dichloride

Radionuclide therapy with 223Ra-dichloride is used to treat bone metastases and to improve the quality of life of patients with metastatic castration-resistant prostate cancer. At the present time there is no reliable data on the biodistribution of the 223Ra-dichloride in the patient body. The aim o...

Full description

Bibliographic Details
Main Authors: L. A. Chipiga, A. E. Petrova, A. V. Vodovatov, A. A. Stanzhevsky, A. A. Lumpov, D. D. Lavreshov, L. E. Naurzbaeva, S. M. Kushnarenko, A. A. Mosunov
Format: Article
Language:English
Published: Saint-Petersburg Research Institute of Radiation Hygiene after Professor P.V. Ramzaev 2020-12-01
Series:Radiacionnaâ Gigiena
Subjects:
radionuclide therapy
223ra-dichloride
prostate cancer
radiopharmaceuticals
internal dose
absorbed doses in organs
equivalent dose
effective dose
Online Access:https://www.radhyg.ru/jour/article/view/747

Internet

https://www.radhyg.ru/jour/article/view/747

Similar Items